Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.
1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.
Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.
Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.
From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.
The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.
April 28-30, 2024
November 16, 2023 - In-Person in Munich
October 27, 2023
On Wednesday, the Patent Trial and Appeal Board (PTAB) invalidated a prenatal DNA test patent owned by Stanford University in a victory for Oblon Spivak client Ariosa Diagnostics.
In a final written decision in an inter partes review under the America Invents Act (AIA), the board found that Stanford's U.S. Patent Number 8,296,076 on a method of detecting chromosomal abnormalities in a fetus, such as those related to Down Syndrome, is invalid as anticipated and obvious.
Oblon Spivak’s Post-Grant Patent Practice handles all aspects of USPTO post-issuance proceedings, including practice before the Patent Trial and Appeal Board (PTAB), and appeals to the Court of Appeals for the Federal Circuit (CAFC). Oblon Spivak’s post-grant practitioners are some of the most experienced in the country and the group has settled more inter partes review proceedings than most firms have filed in total.
The Ariosa Diagnostics win was covered by Law360 and can be read by subscribers here.